220 related articles for article (PubMed ID: 10393456)
21. Iomeprol: a review of its use as a contrast medium.
Dooley M; Jarvis B
Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
[TBL] [Abstract][Full Text] [Related]
22. Fixed drug eruption by etoricoxib confirmed by patch test.
Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
[TBL] [Abstract][Full Text] [Related]
23. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
24. Late phase allergic reaction to a CT contrast medium (iotrolan).
Kanzaki T; Sakagami H
J Dermatol; 1991 Sep; 18(9):528-31. PubMed ID: 1838559
[TBL] [Abstract][Full Text] [Related]
25. [Individual management permits contrast media enhanced CT examination without premedication ].
Böhm I; Pfützner W; Klose KJ
Rofo; 2012 Dec; 184(12):1161-2. PubMed ID: 22851297
[No Abstract] [Full Text] [Related]
26. Cycloserine-induced lichenoid drug eruption.
Shim JH; Kim TY; Kim HO; Kim CW
Dermatology; 1995; 191(2):142-4. PubMed ID: 8520062
[TBL] [Abstract][Full Text] [Related]
27. Fixed drug eruption presenting as erythema dyschromicum perstans: a flare without taking any medications.
Mizukawa Y; Shiohara T
Dermatology; 1998; 197(4):383-5. PubMed ID: 9873180
[TBL] [Abstract][Full Text] [Related]
28. Fixed eruption due to quinine: report of two cases.
Muso Y; Kentarou O; Itami S; Yoshikawa K
J Dermatol; 2007 Jun; 34(6):385-6. PubMed ID: 17535404
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility and safety profile of iomeprol.
Rosati G
Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
[TBL] [Abstract][Full Text] [Related]
30. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
31. Intravascular immune hemolysis caused by the contrast medium iomeprol.
Mayer B; Leo A; Herziger A; Houben P; Schemmer P; Salama A
Transfusion; 2013 Oct; 53(10):2141-4. PubMed ID: 23347254
[TBL] [Abstract][Full Text] [Related]
32. [Iomeprol: results of clinical trials with a new nonionic contrast medium in children].
van Gessel R; Möller A; Schmiedel E
Aktuelle Radiol; 1994 Sep; 4(5):225-8. PubMed ID: 7986838
[TBL] [Abstract][Full Text] [Related]
33. Multiple fixed drug eruption due to drug combination.
Yokoyama A; Hara H
Contact Dermatitis; 2005 Jun; 52(6):339-41. PubMed ID: 15932587
[TBL] [Abstract][Full Text] [Related]
34. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S; John AM; Handler MZ; Schwartz RA
Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
[TBL] [Abstract][Full Text] [Related]
35. Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
Lexmaulova L; Zatloukal J; Proks P; Dvorak M; Srnec R; Rauser P; Kecova H; Necas A
J Vet Emerg Crit Care (San Antonio); 2009 Dec; 19(6):611-6. PubMed ID: 20017767
[TBL] [Abstract][Full Text] [Related]
36. Elimination of iomeprol by hemodialysis.
Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Sakaguchi K
Eur J Radiol; 1996 Nov; 23(3):197-200. PubMed ID: 9003924
[TBL] [Abstract][Full Text] [Related]
37. Two contrasting post-zoster dermatomal phenomena.
Sultan SJ; Sameem F
Skinmed; 2012; 10(5):312-4. PubMed ID: 23163077
[TBL] [Abstract][Full Text] [Related]
38. [A case of fixed drug eruption due to ephedrine hydrochloride].
Tanimoto K; Shimakage T; Ayabe Y; Yamakawa T; Kumekawa M; Moriyama S
Masui; 2000 Dec; 49(12):1374-6. PubMed ID: 11193515
[TBL] [Abstract][Full Text] [Related]
39. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.
Sutton AG; Finn P; Campbell PG; Price DJ; Hall JA; Stewart MJ; Davies A; Linker NJ; De Belder MA
J Invasive Cardiol; 2003 Mar; 15(3):133-8. PubMed ID: 12612387
[TBL] [Abstract][Full Text] [Related]
40. Erythematous-violaceous and bullous skin lesions after administration of iodinated contrast in a patient on hemodialysis. A case of fixed drug eruption due to iodinated contrast.
Cabana Carcasi ML; Santana Romero SR; Beato Coo L; Marcos Bravo MC
Nefrologia (Engl Ed); 2023; 43(4):508-510. PubMed ID: 37689537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
